# Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma

> **NCT00059839** · PHASE3 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 129 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** doxorubicin hydrochloride
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** prednisone
- **DRUG:** vinblastine sulfate
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00059839
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2009-12
- **Final completion:** 2014-07
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2014-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00059839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00059839, "Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00059839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*